AAAAAA
Results: 151-175/238
Authors:
IQBAL N
VANPRAAG HM
Citation: N. Iqbal et Hm. Vanpraag, THE ROLE OF SEROTONIN IN SCHIZOPHRENIA, European neuropsychopharmacology, 5, 1995, pp. 11-23
Authors:
SEDVALL G
PAULI S
KARLSSON P
FARDE L
NORDSTROM AL
NYBERG S
HALLDIN C
Citation: G. Sedvall et al., PET IMAGING OF NEURORECEPTORS IN SCHIZOPHRENIA, European neuropsychopharmacology, 5, 1995, pp. 25-30
Authors:
HENN S
BASS N
SHIELDS G
CROW TJ
DELISI LE
Citation: S. Henn et al., AFFECTIVE-ILLNESS AND SCHIZOPHRENIA IN FAMILIES WITH MULTIPLE SCHIZOPHRENIC MEMBERS - INDEPENDENT ILLNESSES OR VARIANT GENE(S), European neuropsychopharmacology, 5, 1995, pp. 31-36
Authors:
ANDREASEN NC
SWAYZE V
OLEARY DS
NOPOULOS P
CIZADLO T
HARRIS G
ARNDT S
FLAUM M
Citation: Nc. Andreasen et al., ABNORMALITIES IN MIDLINE ATTENTIONAL CIRCUITRY IN SCHIZOPHRENIA - EVIDENCE FROM MAGNETIC-RESONANCE AND POSITRON EMISSION TOMOGRAPHY, European neuropsychopharmacology, 5, 1995, pp. 37-41
Authors:
BENKERT O
MULLERSIECHENEDER F
WETZEL H
Citation: O. Benkert et al., DOPAMINE AGONISTS IN SCHIZOPHRENIA - A REVIEW, European neuropsychopharmacology, 5, 1995, pp. 43-53
Authors:
ALTAMURA AC
TACCHINI GL
MAES M
Citation: Ac. Altamura et al., HALOPERIDOL PLASMA THRESHOLD LEVELS FOR RELAPSE PREVENTION IN SCHIZOPHRENIA - A STUDY WITH HALOPERIDOL DECANOATE, European neuropsychopharmacology, 5, 1995, pp. 55-58
Authors:
CROW TJ
Citation: Tj. Crow, A THEORY OF THE EVOLUTIONARY ORIGINS OF PSYCHOSIS, European neuropsychopharmacology, 5, 1995, pp. 59-63
Authors:
PEREZ J
MORI S
CAIVANO M
POPOLI M
ZANARDI R
SMERALDI E
RACAGNI G
Citation: J. Perez et al., EFFECTS OF FLUVOXAMINE ON THE PROTEIN-PHOSPHORYLATION SYSTEM ASSOCIATED WITH RAT NEURONAL MICROTUBULES, European neuropsychopharmacology, 5, 1995, pp. 65-69
Authors:
ALTAMURA C
MAES M
DAI J
MELTZER HY
Citation: C. Altamura et al., PLASMA-CONCENTRATIONS OF EXCITATORY AMINO-ACIDS, SERINE, GLYCINE, TAURINE AND HISTIDINE IN MAJOR DEPRESSION, European neuropsychopharmacology, 5, 1995, pp. 71-75
Authors:
STOKES PE
Citation: Pe. Stokes, THE POTENTIAL ROLE OF EXCESSIVE CORTISOL INDUCED BY HPA HYPERFUNCTIONIN THE PATHOGENESIS OF DEPRESSION, European neuropsychopharmacology, 5, 1995, pp. 77-82
Authors:
PARIANTE CM
MILLER AH
Citation: Cm. Pariante et Ah. Miller, NATURAL-KILLER-CELL ACTIVITY IN MAJOR DEPRESSION - A PROSPECTIVE-STUDY OF THE IN-VIVO EFFECTS OF DESMETHYLIMIPRAMINE TREATMENT, European neuropsychopharmacology, 5, 1995, pp. 83-88
Authors:
GESSA GL
PANI L
FADDA P
FRATTA W
Citation: Gl. Gessa et al., SLEEP-DEPRIVATION IN THE RAT - AN ANIMAL-MODEL OF MANIA, European neuropsychopharmacology, 5, 1995, pp. 89-93
Authors:
ANGST J
Citation: J. Angst, THE EPIDEMIOLOGY OF DEPRESSIVE-DISORDERS, European neuropsychopharmacology, 5, 1995, pp. 95-98
Authors:
ALTAMURA AC
CARTA MG
CARPINIELLO B
PIRAS A
MACCIO MV
MARCIA L
Citation: Ac. Altamura et al., LIFETIME PREVALENCE OF BRIEF RECURRENT DEPRESSION (RESULTS FROM A COMMUNITY SURVEY), European neuropsychopharmacology, 5, 1995, pp. 99-102
Authors:
CARTA MG
CARPINIELLO B
KOVESS V
PORCEDDA R
ZEDDA A
RUDAS N
Citation: Mg. Carta et al., LIFETIME PREVALENCE OF MAJOR DEPRESSION AND DYSTHYMIA - RESULTS OF A COMMUNITY SURVEY IN SARDINIA, European neuropsychopharmacology, 5, 1995, pp. 103-107
Authors:
KATONA CLE
Citation: Cle. Katona, REFRACTORY DEPRESSION - A REVIEW WITH PARTICULAR REFERENCE TO THE USEOF LITHIUM AUGMENTATION, European neuropsychopharmacology, 5, 1995, pp. 109-113
Authors:
HUMMER M
KEMMLER G
KURZ M
KURZTHALER I
OBERBAUER H
FLEISCHHACKER WW
Citation: M. Hummer et al., WEIGHT-GAIN INDUCED BY CLOZAPINE, European neuropsychopharmacology, 5(4), 1995, pp. 437-440
Authors:
MARTTILA M
JAASKELAINEN J
JARVI R
ROMANOV M
MIETTINEN E
SORRI P
AHLFORS U
ZIVKOV M
Citation: M. Marttila et al., A DOUBLE-BLIND-STUDY COMPARING THE EFFICACY AND TOLERABILITY OF MIRTAZAPINE AND DOXEPIN IN PATIENTS WITH MAJOR DEPRESSION, European neuropsychopharmacology, 5(4), 1995, pp. 441-446
Authors:
HARRO J
ORELAND L
VASAR E
BRADWEJN J
Citation: J. Harro et al., IMPAIRED EXPLORATORY-BEHAVIOR AFTER DSP-4 TREATMENT IN RATS - IMPLICATIONS FOR THE INCREASED ANXIETY AFTER NORADRENERGIC DENERVATION, European neuropsychopharmacology, 5(4), 1995, pp. 447-455
Authors:
PITKANEN M
SIRVIO J
MACDONALD E
NIEMI S
EKONSALO T
RIEKKINEN P
Citation: M. Pitkanen et al., THE EFFECTS OF D-CYCLOSERINE AND MK-801 ON THE PERFORMANCE OF RATS IN2 SPATIAL-LEARNING AND MEMORY TASKS, European neuropsychopharmacology, 5(4), 1995, pp. 457-463
Authors:
PRZEWLOCKA B
LASON W
Citation: B. Przewlocka et W. Lason, ADAPTIVE-CHANGES IN THE PROENKEPHALIN AND D-2 DOPAMINE-RECEPTOR MESSENGER-RNA EXPRESSION AFTER CHRONIC COCAINE IN THE NUCLEUS-ACCUMBENS ANDSTRIATUM OF THE RAT, European neuropsychopharmacology, 5(4), 1995, pp. 465-469
Authors:
VOS PE
WOLTERINK G
VANREE JM
Citation: Pe. Vos et al., THE BEHAVIORAL-EFFECTS OF HABITUATION AND CHALLENGE WITH APOMORPHINE AFTER 6-OHDA LESIONING OF THE NUCLEUS-ACCUMBENS IN RATS, European neuropsychopharmacology, 5(4), 1995, pp. 471-476
Authors:
KOMORI T
FUJIWARA R
TANIDA M
NOMURA J
Citation: T. Komori et al., POTENTIAL ANTIDEPRESSANT EFFECTS OF LEMON ODOR IN RATS, European neuropsychopharmacology, 5(4), 1995, pp. 477-480
Authors:
HASCOET M
BOURIN M
PAYEUR R
LOMBET A
PEGLION JL
Citation: M. Hascoet et al., SIGMA-LIGAND S14905 AND LOCOMOTOR-ACTIVITY IN MICE, European neuropsychopharmacology, 5(4), 1995, pp. 481-489
Authors:
GOTTFRIES CG
FREDERIKSEN SO
HEILIG M
Citation: Cg. Gottfries et al., NEUROPEPTIDES AND ALZHEIMERS-DISEASE, European neuropsychopharmacology, 5(4), 1995, pp. 491-500